Axogen Inc Asset Resilience Ratio
Axogen Inc asset resilience ratio. Axogen Inc (AXGN) has an Asset Resilience Ratio of 6.55% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Axogen Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Axogen Inc (2011–2025)
Asset resilience ratio of Axogen Inc from 2011 to 2025. This chart shows how Axogen Inc's Asset Resilience Ratio has changed over time. Read AXGN current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Axogen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see AXGN current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $18.95 Million | 6.55% |
| Total Liquid Assets | $18.95 Million | 6.55% |
Asset Resilience Insights
- Limited Liquidity: Axogen Inc maintains only 6.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Axogen Inc Industry Peers by Asset Resilience Ratio
Compare Axogen Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Axogen Inc Asset Resilience Ratio by Year (2011–2025)
Axogen Inc asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for Axogen Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.70% | $5.98 Million | $221.69 Million | -0.21pp |
| 2024-12-31 | 2.91% | $5.93 Million | $203.73 Million | +5.96pp |
| 2023-12-31 | -3.05% | $-6.00 Million | $196.83 Million | -20.20pp |
| 2022-12-31 | 17.15% | $33.51 Million | $195.39 Million | -7.53pp |
| 2021-12-31 | 24.68% | $51.33 Million | $208.02 Million | -2.74pp |
| 2020-12-31 | 27.41% | $55.20 Million | $201.38 Million | -11.90pp |
| 2019-12-31 | 39.31% | $60.79 Million | $154.64 Million | -18.32pp |
| 2018-12-31 | 57.63% | $92.31 Million | $160.17 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $58.87 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $46.36 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $37.55 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $16.40 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $27.68 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $20.23 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $12.50 Million | -- |
About Axogen Inc
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed periphera… Read more